Last reviewed · How we verify

NCT03081611: RAMCAN

RAM Cannula VS Short Nasal Prongs for Delivering NIPPV in Preterm Infants

Completed NA Last updated 18 February 2020
What this trial tests

NA trial testing Ram cannula in Respiratory Distress Syndrome, Newborn in 166 participants. Completed in 30 January 2020.

Timeline
1 January 2018
Primary endpoint
30 December 2019
30 January 2020

Quick facts

Lead sponsorRambam Health Care Campus
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment166
Start date1 January 2018
Primary completion30 December 2019
Estimated completion30 January 2020
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Rambam Health Care Campus — full company profile →

Who can join

Under 28 Days, any sex, with Respiratory Distress Syndrome, Newborn or Noninvasive Ventilation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized control trial, Ram cannula VS short nasal prongs for delivering Non Invasive Positive Pressure Ventilation (NIPPV) for preterm infants

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Cannula With Long and Narrow Tubing vs Short Binasal Prongs for Noninvasive Ventilation in Preterm Infants: Noninferiority Randomized Clinical Trial.
    Hochwald O, Riskin A, Borenstein-Levin L, Shoris I, et al · · 2021 · cited 20× · PMID 33165539 · DOI 10.1001/jamapediatrics.2020.3579

Verify or expand the search:

Other recruiting trials for Respiratory Distress Syndrome, Newborn

Currently open trials in the same condition.

Other Rambam Health Care Campus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03081611.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing